AtriCure Receives FDA 510(k) Clearance For Multifunctional Isolator(TM) Transpolar (TM) Pen System And Releases New (Medical News Today)
AtriCure, Inc. [click link for full article]

FDA Approves Expansion of Cardiovascular Systems Inc. Clinical Trial of the Orbital Atherectomy System for Treatment of (RedNova)
ST. PAUL, Minn., July 19 /PRNewswire/ -- Cardiovascular Systems, Inc. (CSI) announced today that the U.S. Food and Drug Administration (FDA) has approved the expansion of the OASIS clinical trial following review of the safety data from the feasibility phase of the study.

Barr Prepared to Satisfy FTC Requirements for Potential Acquisition of PLIVA d.d. (PR Newswire via Yahoo! Finance)
Barr Pharmaceuticals, Inc. today announced that it is prepared to satisfy any requirements that the U.S. Federal Trade Commission might impose regarding the Company's proposed tender offer to purchase 100% of the shares of PLIVA d.d. , based in Zagreb, Croatia.